Poland· PL-100053128
Pimafucin
A natamycin product containing natamycinum, registered in Poland by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 3 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Natamycin is registered in 3 of 19 countries.
Countries holding a registration under ATC D01AA02 (natamycin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Natamycin · ATC D01AA02
3 / 19 countries
- Czechiaprice
- Finlandprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Natamycinum
- Manufacturer
- CHEPLAPHARM Arzneimittel GmbH
- Country
- Poland (PL)
- ATC code
- D01AA02
- ATC class
- Natamycin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990191819
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natamycin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPIMAFUCINCHEPLAPHARM Arzneimittel GmbH, Greifswald
- FinlandPimafucinParanova Oy
- Japanピマリシン千寿製薬
- United KingdomNatacyn 5% ophthalmic suspensionImported (United States)
- United StatesNATACYNHarrow Eye, LLC
- NorwayNatacyn
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Czechia · Pimafucin
- Finland · Pimafucin
- Hungary · Pimafucin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8c07ad8-4ad0-444d-b803-0436ca5db318 GET /v1/drugs/a8c07ad8-4ad0-444d-b803-0436ca5db318?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem",
"source": "urpl",
"strength": "20 mg/g",
"packaging": "05909990191819 ¦ Rp ¦ 43398\n1 op. 30 g",
"substance": "Natamycinum 20 mg",
"common_name": "Natamycinum",
"pl_product_id": "100053128",
"pozwolenie_nr": "01918",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about natamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.